Concepedia

Michael Egan

ME

Statistics

Publications

20

Citations

2.6K

H-Index

18

Active since

1980

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Lou Ruvo Brain Institute

National Institutes of Health

Inserm

National Institute of Mental Health

Michael Egan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, neuropharmacology, and pharmacology.

Publications per year

1980–2024

20

Publications

20

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

Michael Egan, James Kost, Pierre N. Tariot et al. · New England Journal of Medicine · 2018 · 678 citations · Full text

, , +17

Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

Michael Egan, James Kost, Tiffini Voss et al. · New England Journal of Medicine · 2019 · 548 citations · Full text

, , +17

Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia

Caleb M. Adler, Anil K. Malhotra, Igor Elman et al. · American Journal of Psychiatry · 1999 · 338 citations

, , +14

Relative Risk of Attention Deficits in Siblings of Patients With Schizophrenia

Michael Egan, Terry E. Goldberg, Tonya Gscheidle et al. · American Journal of Psychiatry · 2000 · 184 citations

, , +17

Parental Schizophrenia Spectrum Disorders in Childhood-Onset and Adult-Onset Schizophrenia

Rob Nicolson, Frances B. Brookner, Marge Lenane et al. · American Journal of Psychiatry · 2003 · 102 citations

, , +15

1–5 of 20